Small molecule drug discovery platform targeting RNA structures
At a glance
- HQ: Durham
- Sector: Biotech
- Stage: Series A
- Last round: Series A
The rest of this record is behind a free account.
Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately, and I read every signup.